Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 16 of about 8 companies and 8 funds for William R. Ward
Company Exchange Symbol Last price Quote change Market cap
SYSCO Corporation NYSE SYY 40.96 +0.22 (0.54%) 24.08B
Sysco Corporation (Sysco), along with its subsidiaries and divisions, is a North American distributor of food and related products primarily to the ...
Executive:
William B. Day
Greenbrier Companies Inc NYSE GBX 49.31 +0.51 (1.05%) 1.33B
The Greenbrier Companies, Inc. (Greenbrier), formerly Greenbrier Co Inc. is a designer, manufacturer and marketer of railroad freight car equipment in North ...
Executive:
William A. Furman.
Baker Hughes Incorporated NYSE BHI 56.49 +0.72 (1.29%) 24.44B
Baker Hughes Incorporated (Baker Hughes) is engaged in the oilfield services industry. Baker Hughes is a supplier of oilfield services, products, ...
Executive:
William H.
Sangamo Biosciences, Inc. NASDAQ SGMO 15.00 -0.72 (-4.58%) 1.03B
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc ...
Executive:
William R.
Timken Co NYSE TKR 42.87 +0.28 (0.66%) 3.80B
The Timken Company (Timken) develops, manufactures, markets and sells products for friction management and mechanical power transmission.
Executive:
William R. Burkhart.
Donaldson Company, Inc. NYSE DCI 38.30 -0.01 (-0.03%) 5.26B
Donaldson Company, Inc. (Donaldson) is a worldwide manufacturer of filtration systems and replacement parts. The Company's product mix includes air and ...
Executive:
William M.
Halma plc LON HLMA 675.50 -6.50 (-0.95%) 2.62B
Halma plc makes products, which protect life and improve the life for people worldwide. The Company operates in four sectors: Process Safety, ...
Executive:
William Anthony Rice.
Calithera Biosciences Inc NASDAQ CALA 28.86 +0.11 (0.38%) 517.47M
Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company is focused on discovering and developing small molecule drugs directed ...
Executive:
William D. Waddill.
Mutual Fund Symbol Nav Nav change
MFS� Diversified Income Fund Class A DIFAX 12.60 +0.14 (1.12%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class C DIFCX 12.60 +0.15 (1.20%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class I DIFIX 12.60 +0.14 (1.12%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class R2 DIFEX 12.60 +0.15 (1.20%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class R4 DIFGX 12.61 +0.15 (1.20%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class R3 DIFFX 12.61 +0.15 (1.20%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class R1 DIFDX 12.58 +0.14 (1.13%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS� Diversified Income Fund Class R5 DIFHX 12.60 +0.14 (1.12%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.